No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
NBRVF Nabriva Therapeutics PLC
- 0.000
- 0.0000.00%
15min DelayClose Jan 2 16:00 ET
3.23Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)3.23MShares0.52452wk High0.00P/B3.22Float Cap0.00052wk Low--Dividend TTM3.22MShs Float4370.000Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
The World Needs New Antibiotics. The Problem Is, No One Can Make Them Profitably. -- Update
The World Needs New Antibiotics, but the Business Model Is Broken -- WSJ
News On Nabriva Therapeutics PLC (NBRV) Now Under NBRVF
Arbutus Biopharma Appoints Karen Sims as Chief Medical Officer
Arbutus Biopharma Promotes Dr. Karen Sims to Chief Medical Officer, Hires Christopher Naftzger as Chief Compliance Officer
Arbutus Appoints Two New Executives
Heat List
US
Overall
Symbol
Price
% Chg
No Data